SOD1 and amyotrophic lateral sclerosis: In contrast to LOF, an integrative proteomics-based regulatory network study by Mishra and colleagues52 have recently found that ligand-receptor interactions mediate a toxic gain of SOD1 ALS astrocyte function through releasing APP that exerts MN toxicity by DC6-signalling.